InvestorsHub Logo
Followers 0
Posts 572
Boards Moderated 0
Alias Born 09/29/2010

Re: ChartDad101 post# 3985

Friday, 04/15/2011 3:05:25 PM

Friday, April 15, 2011 3:05:25 PM

Post# of 58344
"The Company had also anticipated that it would be generating revenue by mid 2010 through the commercialization of technologies currently owned or acquired by the Company, principally its Canker Kill product. However, label delays for the Canker Kill product at the EPA has pushed back commercialization of this product approximately 18 months to the middle of 2011 or early 2012 and an inability to raise large amounts of capital has delayed our ability to acquire and commercialize other technologies."